Published in Eur Heart J on March 09, 2010
Microvascular coronary dysfunction and ischemic heart disease: where are we in 2014? Trends Cardiovasc Med (2014) 1.46
Coronary microvascular dysfunction: an update. Eur Heart J (2013) 1.28
Impaired coronary microvascular reactivity in women with apical ballooning syndrome (Takotsubo/stress cardiomyopathy). Eur Heart J Acute Cardiovasc Care (2013) 1.21
Takotsubo cardiomyopathy: Pathophysiology, diagnosis and treatment. World J Cardiol (2014) 1.11
Coronary microvascular dysfunction in the clinical setting: from mystery to reality. Eur Heart J (2012) 1.07
Takotsubo cardiomyopathy--a clinical review. Med Sci Monit (2011) 0.99
The protective effect of microRNA-320 on left ventricular remodeling after myocardial ischemia-reperfusion injury in the rat model. Int J Mol Sci (2014) 0.86
Takotsubo cardiomyopathy. Heart Fail Rev (2014) 0.80
Diagnosis of coronary microvascular dysfunction - Present status. Indian Heart J (2015) 0.76
Recurrent transient apical cardiomyopathy (tako-tsubo-like left ventricular dysfunction) in a postmenopausal female with diffuse esophageal spasms. Heart Views (2013) 0.75
Takotsubo Cardiomyopathy Associated with Severe Hypothyroidism in an Elderly Female. Heart Views (2016) 0.75
Use of contrast echocardiography in intensive care and at the emergency room. Curr Cardiol Rev (2011) 0.75
Low MMP-8/TIMP-1 reflects left ventricle impairment in takotsubo cardiomyopathy and high TIMP-1 may help to differentiate it from acute coronary syndrome. PLoS One (2017) 0.75
Apical myocardial infarction with bizarre coronary images mimicking left ventricular apical ballooning syndrome: a case report. J Med Case Rep (2014) 0.75
The natural history of takotsubo syndrome: a two-year follow-up study with myocardial sympathetic and perfusion G-SPECT imaging. Eur J Nucl Med Mol Imaging (2016) 0.75
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54
Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med (2015) 6.00
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J (2006) 5.79
Coronary microvascular dysfunction. N Engl J Med (2007) 5.22
High prevalence of myocarditis mimicking arrhythmogenic right ventricular cardiomyopathy differential diagnosis by electroanatomic mapping-guided endomyocardial biopsy. J Am Coll Cardiol (2009) 3.86
Myocardial no-reflow in humans. J Am Coll Cardiol (2009) 3.71
Widespread coronary inflammation in unstable angina. N Engl J Med (2002) 3.60
Relation between stress-induced myocardial perfusion defects on cardiovascular magnetic resonance and coronary microvascular dysfunction in patients with cardiac syndrome X. J Am Coll Cardiol (2008) 2.96
Usefulness of intracardiac echocardiography for the diagnosis of cardiovascular implantable electronic device-related endocarditis. J Am Coll Cardiol (2013) 2.87
Mechanisms of coronary artery spasm. Circulation (2011) 2.78
Manual thrombus-aspiration improves myocardial reperfusion: the randomized evaluation of the effect of mechanical reduction of distal embolization by thrombus-aspiration in primary and rescue angioplasty (REMEDIA) trial. J Am Coll Cardiol (2005) 2.42
Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. Eur Heart J (2005) 2.33
Widespread myocardial inflammation and infarct-related artery patency. Circulation (2004) 2.27
Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction. Circulation (2008) 2.23
Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery. Circulation (2013) 2.19
Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of 11 trials. Eur Heart J (2009) 2.19
Unusual CD4+CD28null T lymphocytes and recurrence of acute coronary events. J Am Coll Cardiol (2007) 2.09
Platelet reactivity in response to mental stress in syndrome X and in stable or unstable coronary artery disease. Thromb Res (2004) 2.05
Prospective evaluation of myocardial ischemia related to post-procedural side-branch stenosis in bifurcated lesions treated by provisional approach with drug-eluting stents. Catheter Cardiovasc Interv (2011) 2.03
Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management. Circulation (2010) 2.03
Prevalence and clinical correlates of early repolarization and J wave in a large cohort of subjects without overt heart disease. J Electrocardiol (2012) 1.99
Eosinophil cationic protein and clinical outcome after bare metal stent implantation. Atherosclerosis (2010) 1.98
Relation of heart rate variability to serum levels of C-reactive protein in patients with unstable angina pectoris. Am J Cardiol (2006) 1.94
Myocardial production of chromogranin A in human heart: a new regulatory peptide of cardiac function. Eur Heart J (2007) 1.81
High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study. Circulation (2010) 1.75
Transient impairment of vasomotion function after successful chronic total occlusion recanalization. J Am Coll Cardiol (2012) 1.70
Plasma levels of thromboxane A2 on admission are associated with no-reflow after primary percutaneous coronary intervention. Eur Heart J (2008) 1.66
High telomerase activity in neutrophils from unstable coronary plaques. J Am Coll Cardiol (2007) 1.61
Abnormal cortical pain processing in patients with cardiac syndrome X. Eur Heart J (2005) 1.60
Association between cardiac autonomic dysfunction and inflammation in type 1 diabetic patients: effect of beta-blockade. Eur Heart J (2007) 1.59
Severity of coronary atherosclerosis in patients with a first acute coronary event: a diabetes paradox. Eur Heart J (2012) 1.54
High-sensitivity C-reactive protein is within normal levels at the very onset of first ST-segment elevation acute myocardial infarction in 41% of cases: a multiethnic case-control study. J Am Coll Cardiol (2011) 1.53
[Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation]. G Ital Cardiol (Rome) (2009) 1.52
Use of a second buddy wire during percutaneous coronary interventions: a simple solution for some challenging situations. J Invasive Cardiol (2005) 1.52
Angiographic assessment of myocardial perfusion in Tako-Tsubo syndrome. Int J Cardiol (2013) 1.52
Thrombus aspiration without additional ballooning or stenting to treat selected patients with ST-elevation myocardial infarction. J Invasive Cardiol (2010) 1.51
The extent of microvascular damage during myocardial contrast echocardiography is superior to other known indexes of post-infarct reperfusion in predicting left ventricular remodeling: results of the multicenter AMICI study. J Am Coll Cardiol (2008) 1.50
Coronary vasospasm secondary to hypercholinergic crisis: an iatrogenic cause of acute myocardial infarction in myasthenia gravis. Int J Cardiol (2005) 1.50
Effect of remote ischemic preconditioning on platelet activation and reactivity induced by ablation for atrial fibrillation. Circulation (2013) 1.50
Thrombus aspiration reduces microvascular obstruction after primary coronary intervention: a myocardial contrast echocardiography substudy of the REMEDIA Trial. J Am Coll Cardiol (2006) 1.50
Peripheral arterial function and coronary microvascular function in patients with variant angina. Cardiology (2014) 1.48
Are the culprit lesions severely stenotic? JACC Cardiovasc Imaging (2013) 1.48
Baseline systemic inflammatory status and no-reflow phenomenon after percutaneous coronary angioplasty for acute myocardial infarction. Int J Cardiol (2006) 1.48
Vascular complications and access crossover in 10,676 transradial percutaneous coronary procedures. Am Heart J (2012) 1.48
Spinal cord stimulation for the treatment of refractory angina pectoris: a multicenter randomized single-blind study (the SCS-ITA trial). Pain (2010) 1.47
Persistent systemic inflammation in unstable angina is largely unrelated to the atherothrombotic burden. J Am Coll Cardiol (2005) 1.46
Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study). J Am Coll Cardiol (2002) 1.46
Relation between cardiovascular risk factors and coronary microvascular dysfunction in cardiac syndrome X. J Cardiovasc Med (Hagerstown) (2011) 1.46
Delayed neutrophil apoptosis in patients with unstable angina: relation to C-reactive protein and recurrence of instability. Eur Heart J (2009) 1.46
Relationship between cardiac autonomic function and sustained ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillators. Europace (2010) 1.45
Outcome of patients treated by a novel thin-strut cobalt-chromium stent in the drug-eluting stent era: Results of the SKICE (Skylor in real world practice) registry. Catheter Cardiovasc Interv (2009) 1.45
Urgent PCI in patients with stent thrombosis: an observational single-center study comparing thrombus aspiration and standard PCI. J Invasive Cardiol (2008) 1.44
Coronary microvascular function and cortical pain processing in patients with silent positive exercise testing and normal coronary arteries. Am J Cardiol (2012) 1.43
Upper arm intermittent ischaemia reduces exercise-related increase of platelet reactivity in patients with obstructive coronary artery disease. Heart (2011) 1.43
Predictors of thromboxane levels in patients with non-ST-elevation acute coronary syndromes on chronic aspirin therapy. Thromb Haemost (2012) 1.42
Lack of effect of nitrates on exercise stress test results in patients with microvascular angina. Cardiovasc Drugs Ther (2013) 1.42
Procedural and clinical evaluation of the novel zotarolimus-eluting resolute stent in patients with unselected bifurcated coronary stenosis treated by provisional approach: a multicenter registry. J Invasive Cardiol (2011) 1.42
New insights into molecular mechanisms of diffuse coronary ectasiae: a possible role for VEGF. Int J Cardiol (2006) 1.41
Endothelial and smooth muscle cells dysfunction distal to recanalized chronic total coronary occlusions and the relationship with the collateral connection grade. JACC Cardiovasc Interv (2012) 1.41
Feasibility of sequential thrombus aspiration and filter distal protection in the management of very high thrombus burden lesions. J Invasive Cardiol (2007) 1.40
[Inflammation in acute coronary syndromes: mechanisms and clinical implications]. Rev Esp Cardiol (2004) 1.40
Myogenic potential of adipose-tissue-derived cells. J Cell Sci (2006) 1.39
Provisional TAP-stenting strategy to treat bifurcated lesions with drug-eluting stents: one-year clinical results of a prospective registry. J Invasive Cardiol (2009) 1.39
Instability mechanisms in unstable angina according to baseline serum levels of C-reactive protein: the role of thrombosis, fibrinolysis and atherosclerotic burden. Int J Cardiol (2007) 1.39
T-wave alternans in apparently healthy subjects and in different subsets of patients with ischaemic heart disease. Europace (2011) 1.38
Poor tolerance and limited effects of isosorbide-5-mononitrate in microvascular angina. Cardiology (2015) 1.38
Bivalirudin versus unfractionated heparin for residual thrombus burden: a frequency-domain optical coherence tomography study. Catheter Cardiovasc Interv (2014) 1.37
Exercise stress test results in patients with bare metal stents or drug-eluting stents: pathophysiological and clinical implications. Circ J (2010) 1.36
Rate-control vs. rhythm-control in patients with atrial fibrillation: a meta-analysis. Eur Heart J (2005) 1.34
Polycythemia vera. Intern Emerg Med (2010) 1.32
Current clinical features, diagnostic assessment and prognostic determinants of patients with variant angina. Int J Cardiol (2006) 1.32
From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells. Eur Heart J (2009) 1.29
Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients. Eur Heart J (2005) 1.26
Sex-related differences in myocardial remodeling. J Am Coll Cardiol (2010) 1.25
A randomized comparison of alternative techniques to achieve coronary sinus cannulation during biventricular implantation procedures. J Interv Card Electrophysiol (2004) 1.24
Endogenous G-CSF and CD34+ cell mobilization after acute myocardial infarction. Int J Cardiol (2005) 1.23
Inflammation as a possible link between coronary and carotid plaque instability. Circulation (2004) 1.23
Insulin-like growth factor-1 as a vascular protective factor. Circulation (2004) 1.21
MicroRNA signatures in peripheral blood mononuclear cells of chronic heart failure patients. Physiol Genomics (2010) 1.17
Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus. Eur Heart J (2011) 1.17
CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases. Atherosclerosis (2008) 1.15
Antibody response to chlamydial heat shock protein 60 is strongly associated with acute coronary syndromes. Circulation (2003) 1.14
Paradoxical preservation of vascular function in severe obesity. Am J Med (2010) 1.08
Gene expression profiles in peripheral blood mononuclear cells of chronic heart failure patients. Physiol Genomics (2009) 1.07
Identification of protein disulfide isomerase as a cardiomyocyte survival factor in ischemic cardiomyopathy. J Am Coll Cardiol (2007) 1.07
Opposite patterns of left ventricular remodeling after coronary revascularization in patients with ischemic cardiomyopathy: role of myocardial viability. Circulation (2004) 1.05